Join the clinician pilot Request the investor deck

In development · ADHD first

Objective cognitive measures for ADHD and attention concerns first; memory concerns and cognitive change later.

From a link, not a testing room.

A browser-based cognitive assessment that clinicians order and patients complete at home in about 30 minutes, with a report designed for the clinician who ordered it.

In developmentNot FDA clearedNot for clinical use: read our regulatory status
RT distribution · ex-GaussianIllustrative
Illustrative reaction-time distribution An abstract ex-Gaussian curve drawn from synthetic parameters: a peak near 430 milliseconds and a long right-hand tail. Not patient data. 2004006008001000 MODE ≈ 430 MS τ · SLOW-RESPONSE TAIL EXPONENTIAL COMPONENT REACTION TIME (MS) →
μ 380 · σ 45 · τ 110 msSynthetic parameters · not patient data

The tests exist. They aren't routine yet.

The continuous performance test, a core measure of sustained attention, has been studied since 1956, and FDA-cleared computerized attention and cognitive tests are on the market, some of which run at home. Even so, many attention and memory concerns are still assessed with interviews and rating scales alone.

15.5million

U.S. adults with a current ADHD diagnosis. About half were diagnosed as adults.

SourceCDC, MMWR, 2024

7.4million

Americans 65 and older living with Alzheimer's dementia in 2026.

SourceAlzheimer's Association, 2026 Facts and Figures

<1 in 3

Fewer than one in three Medicare beneficiaries 65 and older in a national internet-panel survey (through 2019) reported a structured cognitive assessment, though Medicare's Annual Wellness Visit requires detection of cognitive impairment.

SourceJacobson et al., Health Affairs, 2020 · 42 CFR 410.15

A cognitive battery that runs in a browser tab.

  • One battery, two clinical questions.

    One task engine designed to cover ADHD first, then cognitive decline, with memory tasks added. Planned, not yet validated.

  • Adaptive within a standardized protocol.

    The core attention task is designed to run a fixed, standardized protocol so scores can be compared with norms. Practice trials and working-memory difficulty are planned to adjust by fixed rules that are part of the protocol, so the norms cover them too.

  • A report designed for the visit.

    Session validity first, then domain scores against normative comparisons once norms exist, then the measures underneath. Later, AI-drafted notes that the clinician reviews, edits, and signs.

  • No camera, no install.

    Designed to run in a current browser on a modern laptop or desktop, ordered like a lab test and designed to fit existing billing codes. Device timing is designed to be checked in every session.

Ordered by a clinician. Finished at home. Read by a clinician.

  1. Order.

    The clinician picks a battery for the clinical question and sends the patient a link.

  2. Test.

    The patient spends about 30 minutes on tasks in a web browser at home.

  3. Report.

    Scoring and validity checks are designed to run automatically. Our target is a structured report to the clinician within 24 hours, including a quality check during the pilot.

  4. Decide.

    The clinician reads it alongside history, interview, and rating scales, and makes the call.

Designed to support a clinician's judgment. It does not diagnose.

Illustrative — synthetic data · not a real patient

Sample report · Synthetic data

Patient: Sample A · Adult · Session valid

1  Validity

  • Effort checksPassed
  • Device timingWithin tolerance

2  Sustained attention

d′NON-TARGETTARGETCRITERION

d′ (target sensitivity) · omissions · commissions

3  Response-time profile

τ · SLOW TAILRESPONSE TIME →

RT variability · ex-Gaussian τ (slow-response tail)

4  Normative comparison

  • Sustained attention
  • Response inhibition
  • Working memory
  • Processing speed

Sample positionReference band

Shown against a reference band for age

Not a diagnosis. Interpret with the full clinical picture.

Illustrative example using synthetic data. Not a real patient. Not a diagnostic output.

Illustrative sample

What a clinician would see.

Validity first. Then a one-page summary by cognitive domain, with the raw measures one click deeper.

  • 1ValidityEffort checks and device timing, before any score is shown.
  • 2Sustained attentiond′ (target sensitivity), omissions, and commissions.
  • 3Response-time profileRT variability and the ex-Gaussian τ, the slow-response tail.
  • 4Normative comparisonShown against a reference band for age.

No risk score, no probability, no diagnostic label. Reference bands in this sample are synthetic.

Join the clinician pilot

How it compares.

FDA-cleared computerized attention tests already run in clinics and, with a webcam, at home. Computerized cognitive batteries, many of them FDA-regulated, are used for memory concerns. What we're building, and haven't yet validated, is one camera-free browser battery for both clinical questions, starting with ADHD, with validity checks in every session, a report layer for the ordering clinician, and an ordering flow designed around clinic workflow and billing.

Categories describe common practice; individual products differ. The ATTNhealth column lists design goals, not demonstrated performance.
DimensionInterview and rating scales aloneFDA-cleared computerized attention testsComputerized cognitive batteriesFull neuropsychological evaluationATTNhealth (design goals)
Objective performance dataNo. Self- and observer reportYes, attention-focusedYes, multi-domainYes, broadYes: attention, working memory, processing speed
Where it happensClinic or telehealth visitClinic, or at home with a webcam (some products)Clinic or remote, by productSpecialist's officeHome, in a web browser
EquipmentNoneClinic equipment, or the patient's computer and webcam (some products)Computer, tablet, or dedicated device, by productTesting materials and a trained examinerA laptop or desktop; no camera
Patient timeMinutesTypically 15–25 minutesVaries by productOften several hoursAbout 30 minutes
Effort and validity checksSome scales include validity indicesProduct-specificProduct-specificYes, examiner-chosenDesigned into every session
Regulatory statusn/aFDA clearedMany FDA-regulated (Class II); see each product's labelingn/aIn development. Not FDA cleared

Who's building it

He treats the patients who need these tests.

ATTNhealth's founder is an MD, PhD psychiatrist and endowed associate professor of psychiatry at an Ivy League medical school. He treats adults with ADHD and has 100+ peer-reviewed publications. Name and CV on request.

  • ClinicalTreats adults with ADHD
  • ResearchLeads an academic research lab
  • Record100+ peer-reviewed publications

Academic roles are described for context only. ATTNhealth is an independent company.

Read the full story

Now, next, later.

Now

  • In progress

    Building the core ADHD battery

    Attention, working memory, processing speed.

  • In progress

    Recruiting clinician pilot partners

Next

  • Planned

    Device timing and test–retest reliability studies

  • Planned

    IRB-approved validation study

    In adults referred for ADHD evaluation.

  • Planned

    Normative reference data collection

  • Planned

    FDA pre-submission meeting

    To confirm device type, predicate, and data requirements.

Later

  • Planned

    510(k) submission for the ADHD battery, if the data support it

  • Planned

    Cognitive-decline battery and its validation

  • Planned

    Clinician-reviewed AI interpretive drafts

Pilot it with us, or follow the build.

Clinicians and health systems

Shape the first version in your clinic.

A small group of pilot partners will see it early, help shape what the report shows, and help validate it.

Join the clinician pilot
Investors

Materials on request.

The plan, the validation roadmap, and the regulatory strategy, sent by the founder.

Request the investor deck

Looking for testing for yourself or your child? ATTNhealth isn't available yet, the first version is for adults, and it will be ordered by clinicians. We can't give medical advice. If you're concerned about attention or memory, please talk with your doctor.

Sources (5)

  1. Staley BS, et al. ADHD Diagnosis, Treatment, and Telehealth Use in Adults — United States, Oct–Nov 2023. MMWR 2024;73(40):890–895. cdc.gov
  2. Alzheimer's Association. 2026 Alzheimer's Disease Facts and Figures. alz.org
  3. Jacobson M, Thunell JA, Zissimopoulos J. Cognitive Assessment at Medicare's Annual Wellness Visit in Fee-for-Service and Medicare Advantage Plans. Health Affairs 2020. PMC9517732
  4. 42 CFR § 410.15, Annual wellness visits. ecfr.gov
  5. Rosvold HE, et al. A continuous performance test of brain damage. J Consult Psychol 1956;20(5):343–350. doi:10.1037/h0043220